2 Information about somatrogon
Marketing authorisation indication
2.1 Somatrogon (Ngenla, Pfizer) is indicated for 'the treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone'.
Dosage in the marketing authorisation
2.2 The dosage schedule is available in the summary of product characteristics for somatrogon.
Price
2.3 £166.08 per 1.2-ml vial containing 24 mg of somatrogon or £415.20 for a 1.2-ml vial containing 60 mg of somatrogon (excluding VAT, company submission, December 2022). At the recommended dose of 0.66 mg per kg per week the estimated annual cost for a 40 kg patient is £9,500. Costs may vary in different settings because of negotiated procurement discounts.